AnaptysBio, Inc.ANABNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank92
5Y CAGR+7.5%
Year-over-Year Change
Year-over-year operating cash flow growth rate
5Y CAGR
+7.5%/yr
Long-term compound
Percentile
P92
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 114.55% |
| 2024 | -12.03% |
| 2023 | -64.15% |
| 2022 | -60.26% |
| 2021 | -224.36% |
| 2020 | 79.64% |
| 2019 | -43.32% |
| 2018 | -149.54% |
| 2017 | -115.26% |
| 2016 | 6.61% |